WHO: Coronavirus cases declining everywhere except Europe

LONDON – The World Health Organization reported Wednesday that coronavirus deaths rose by 10% in Europe in the past week, making it the only world region where both COVID-19 cases and deaths are steadily increasing. It was the sixth consecutive week that the virus has risen across the continent.

In its weekly report on the pandemic, the U.N. health agency said there were about 3.1 million new cases globally, about a 1% increase from the previous week. Nearly two-thirds of the coronavirus infections – 1.9 million – were in Europe, where cases rose by 7%.

The countries with the highest numbers of new cases worldwide were the United States, Russia, Britain, Turkey and Germany. The number of weekly COVID-19 deaths fell by about 4% worldwide and declined in every region except Europe.

Out of the 61 countries WHO includes in its European region, which includes Russia and stretches to Central Asia, 42% reported a jump in cases of at least 10% in the last week.

In the Americas, WHO said that new weekly cases fell by 5% and deaths declined by 14%, with the highest numbers reported from the United States.

On Tuesday, pharmaceutical company Pfizer asked the U.S. Food and Drug Administration to authorize booster shots of coronavirus vaccines for all adults. WHO has pleaded with countries not to administer more boosters until at least the end of the year; about 60 countries are actively rolling them out.

In Southeast Asia and Africa, COVID-19 deaths declined by about a third, despite the lack of vaccines in those regions.

WHO’s Europe director, Dr. Hans Kluge, said last week that Europe was once again “back at the epicenter of the pandemic.” He warned that if more actions weren’t taken to stop COVID-19, the region could see another 500,000 deaths by February.

  • Related Posts

    4yo snakebite victim given anti-rabies shot at Sambhal hosp; pharmacist removed from duty

    Meerut: A four-year-old boy’s condition allegedly worsened after he was administered an anti-rabies injection at Sambhal district hospital following a snakebite. A pharmacist at the hospital has been removed from…

    Lupin gets tentative US FDA nod for apixaban oral suspension for patients who cannot swallow tablets

    Once final approval comes through, the liquid anticoagulant will be made at Lupin’s plant in Somerset, New Jersey, the company said. Mumbai: Lupin has received tentative approval from the US…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    4yo snakebite victim given anti-rabies shot at Sambhal hosp; pharmacist removed from duty

    4yo snakebite victim given anti-rabies shot at Sambhal hosp; pharmacist removed from duty

    Delhi High Court sets aside FSSAI order asking Red Bull India to drop ‘energy’ from its drinks

    Delhi High Court sets aside FSSAI order asking Red Bull India to drop ‘energy’ from its drinks

    Haryana to use Ayushman, Chirayu claim money for hospital staff incentives and upgrades: CM

    Haryana to use Ayushman, Chirayu claim money for hospital staff incentives and upgrades: CM

    Indian speciality drugs get zero duty as US widens 100% tariff on patented medicines

    Indian speciality drugs get zero duty as US widens 100% tariff on patented medicines

    Low-dose CT screening lowers lung cancer deaths by 16% in high-risk people: IARC

    Low-dose CT screening lowers lung cancer deaths by 16% in high-risk people: IARC

    Krsnaa Diagnostics board clears sale of diagnostic equipment worth up to Rs 120 crore

    Krsnaa Diagnostics board clears sale of diagnostic equipment worth up to Rs 120 crore